Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Harbour BioMed
Biotech
Otsuka's $670M pact to point Harbour's TCE to autoimmune disease
Aiming T-cell engagers at autoimmune diseases continues to be a red-hot dealmaking target.
James Waldron
Jun 23, 2025 6:29am
AstraZeneca details $2.5B investment in China's political center
Mar 21, 2025 8:35am
Harbour launches obesity biotech on mission to preserve muscle
Mar 12, 2025 8:15am
Harbour spinoff pens $395M deal for preclinical Crenessity rival
Feb 26, 2025 5:14am
Windward generates $200M with Novo Holdings, OrbiMed in tow
Jan 10, 2025 10:02am
Cullinan, after $25M deal, hands back bispecific to Harbour
Aug 8, 2024 10:10am